Enteric Disease Testing Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

Published Date : Nov 2020 | No. of Pages : 200 Pages | Category : Healthcare

The enteric disease testing market size was valued at US$ 4 Bn in 2020 and is expected to expand at a CAGR of 3.6% from 2021 to 2030. The global enteric disease testing market size is projected to reach US$ 5.5 billion by 2030.

High morbidity and rapid spread of enteric bacterial infections is projected to drive the global enteric disease testing market during the forecast period.

Enteric diseases are intestinal infections caused by a variety of bacteria, viruses and parasites when they enter the body through the mouth or intestinal systems such as salmonella, shigella, giardia lamblia, campylobacter, cryptosporidium and vibrio cholera causing salmonellosis, shigellosis, giardiasis, campylobacteriosis, cryptosporidiosis and cholera respectively.

High morbidity and rapid spread of enteric bacterial infection to Drive Market

  • Water and foodborne diseases are on the rise globally, especially in underdeveloped and developing nations. Enteric bacteria has been identified as one of the major causative organisms of water and foodborne diseases.
  • Prevalence of diarrhea and hemolytic uremic syndrome (HUS) is increasing rapidly across the world. These are mostly caused by enteric bacterial infection.
  • Various environmental as well as clinical samples are tested regularly to identify enteric bacterial infection contamination and take preventive measures, especially during epidemics, in order to stop the spread of infections. Therefore, rapid increase of water and foodborne enteric bacterial infection boosts demand for enteric disease testing globally.

Bacterial Enteric Disease Segment to Dominate Market

  • Based on disease indication, the global enteric disease testing market has been divided into bacterial enteric disease, viral enteric disease, and parasitic enteric disease. The bacterial enteric disease segment has been bifurcated into C. difficile Infection, Campylobacteriosis, Cholera, E. coli Infection, H. pylori Infection, Salmonellosis, and Shigellosis. The viral enteric disease segment has been bifurcated into Rotavirus Infection, and Norovirus Infection. The parasitic enteric disease segment has been bifurcated into Amebiasis, Cryptosporidiosis, and Giardiasis.

Immunoassay testing to be Highly Lucrative Segment

  • In terms of testing methods, the global enteric disease testing market has been classified into branded immunoassay testing, conventional testing, and molecular diagnostic testing.
  • The immunoassay testing segment dominated the Enteric Disease Testing market due to its rising usage in developing countries such as India, Brazil, and China.

North America to Dominate Global Market

  • In terms of region, the global enteric disease testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Enteric Disease Testing market in 2020, followed by Europe.
  • North America accounted for major share of the global Enteric Disease Testing market in 2020, owing to increasing diagnosis rate for enteric diseases, several market players in the U.S., technological advancements, extensive R&D practices, and increasing awareness about the treatment are likely to boost market growth in the U.S.
  • The enteric disease testing market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2030. Asia Pacific is a fast growing market due to improving health care infrastructure and rising private and public investment in health care facilities in countries such as China and India.

Competitive Landscape

The global enteric disease testing market is fragmented in terms of number of players. Key players in the global market include Meridian Bioscience, Inc., Bio-Rad Laboratories, Inc., Alere, Inc., bioMérieux SA, Trinity Biotech plc, DiaSorin S.p.A., Quest Diagnostics, Coris BioConcept, TECHLAB, Inc., Pro-Lab Diagnostics, Inc., Biomerica, Inc., Becton Dickinson & Company, and Cepheid Inc among others.

Market Segmentation:

By Disease Indication

  • Bacterial Enteric Disease
    • C.difficile Infection
    • Campylobacteriosis
    • Cholera
    • E.coli Infection
    • H.pylori Infection
    • Salmonellosis
    • Shigellosis
  • Viral Enteric Disease
    • Rotavirus Infection
    • Norovirus Infection
  • Parasitic Enteric Disease
    • Amebiasis
    • Cryptosporidiosis
    • Giardiasis

By Testing Methods

    • Immunoassay Testing
    • Conventional Testing
    • Molecular Diagnostic Testing

By Testing Methods

    • Hospitals
    • Diagnostic Laboratories
    • Physician Offices

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global Enteric Disease Testing market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2030. The report provides revenue of the global Enteric Disease Testing market for the period 2017–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Enteric Disease Testing market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Enteric Disease Testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Enteric Disease Testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Enteric Disease Testing market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Enteric Disease Testing market.

The report delves into the competitive landscape of the global Enteric Disease Testing market. Key players operating in the global Enteric Disease Testing market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Enteric Disease Testing market that have been profiled in this report

Key Questions Answered in Global Enteric Disease Testing Market Report

  • What is the scope of growth of product companies in the global Enteric Disease Testing market?
  • What will be the Y-o-Y growth of the global Enteric Disease Testing market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global Enteric Disease Testing market?
  • Will North America continue to be the most profitable market for Enteric Disease Testing providers?
  • Which factors are anticipated to hamper the growth of the global Enteric Disease Testing market during the forecast period?
  • Which are the leading companies in the global Enteric Disease Testing market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global Enteric Disease Testing market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Enteric Disease Testing market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the Enteric Disease Testing market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Enteric Disease Testing market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Enteric Disease Testing market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global Enteric Disease Testing market more reliably and accurately.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Enteric Disease Testing Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Market Opportunity Map

        4.1.3. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Enteric Disease Testing Market Analysis and Forecast, 2017–2030

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Porter’s Five Forces Analysis

    5.2. Major Acquisitions In IVD Industry Snapshot

    5.3. Epidemiology – Major Enteric Disease Infection

6. Global Enteric Disease Testing Market Analysis and Forecast, by Disease Indication

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        6.2.1. Bacterial Enteric Disease

            6.2.1.1. Clostridium Difficile Infection

            6.2.1.2. Campylobacteriosis

            6.2.1.3. Cholera

            6.2.1.4. E. coli Infection

            6.2.1.5. Salmonellosis

            6.2.1.6. H. pylori Infection

            6.2.1.7. Shigellosis

        6.2.2. Viral Enteric Disease

            6.2.2.1. Rotavirus

            6.2.2.2. Norovirus

        6.2.3. Parasitic Enteric Disease

            6.2.3.1. Amebiasis

            6.2.3.2. Cryptosporidiosis

            6.2.3.3. Giardiasis

    6.3. Global Enteric Disease Testing Market Attractiveness, by Disease Indication

7. Global Enteric Disease Testing Market Analysis and Forecast, by Testing Methods

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        7.2.1. Immunoassay Testing

        7.2.2. Conventional Testing

        7.2.3. Molecular Diagnostic Testing

    7.3. Global Enteric Disease Testing Market Attractiveness, by Testing Methods

8. Global Enteric Disease Testing Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        8.2.1. Hospitals

        8.2.2. Diagnostic Laboratories

        8.2.3. Physician Offices

    8.3. Global Enteric Disease Testing Market Attractiveness, by End-user

9. Global Enteric Disease Testing Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Enteric Disease Testing Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. North America Enteric Disease Testing Market Attractiveness, by Region

10. North America Enteric Disease Testing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        10.2.1. Bacterial Enteric Disease

            10.2.1.1. Clostridium Difficile Infection

            10.2.1.2. Campylobacteriosis

            10.2.1.3. Cholera

            10.2.1.4. E. coli Infection

            10.2.1.5. Salmonellosis

            10.2.1.6. H. pylori Infection

            10.2.1.7. Shigellosis

        10.2.2. Viral Enteric Disease

            10.2.2.1. Rotavirus

            10.2.2.2. Norovirus

        10.2.3. Parasitic Enteric Disease

            10.2.3.1. Amebiasis

            10.2.3.2. Cryptosporidiosis

            10.2.3.3. Giardiasis

    10.3. North America Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        10.3.1. Immunoassay Testing

        10.3.2. Conventional Testing

        10.3.3. Molecular Diagnostic Testing

    10.4. North America Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories

        10.4.3. Physician Offices

    10.5. North America Enteric Disease Testing Market Value (US$ Mn) Forecast, by Country, 2017–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Enteric Disease Testing Market Attractiveness Analysis

        10.6.1. By Disease Indication

        10.6.2. By Testing Methods

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Enteric Disease Testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        11.2.1. Bacterial Enteric Disease

            11.2.1.1. Clostridium Difficile Infection

            11.2.1.2. Campylobacteriosis

            11.2.1.3. Cholera

            11.2.1.4. E. coli Infection

            11.2.1.5. Salmonellosis

            11.2.1.6. H. pylori Infection

            11.2.1.7. Shigellosis

        11.2.2. Viral Enteric Disease

            11.2.2.1. Rotavirus

            11.2.2.2. Norovirus

        11.2.3. Parasitic Enteric Disease

            11.2.3.1. Amebiasis

            11.2.3.2. Cryptosporidiosis

            11.2.3.3. Giardiasis

    11.3. Europe Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        11.3.1. Immunoassay Testing

        11.3.2. Conventional Testing

        11.3.3. Molecular Diagnostic Testing

    11.4. Europe Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories

        11.4.3. Physician Offices

    11.5. Europe Enteric Disease Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Enteric Disease Testing Market Attractiveness Analysis

        11.6.1. By Disease Indication

        11.6.2. By Testing Methods

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Enteric Disease Testing Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        12.2.1. Bacterial Enteric Disease

            12.2.1.1. Clostridium Difficile Infection

            12.2.1.2. Campylobacteriosis

            12.2.1.3. Cholera

            12.2.1.4. E. coli Infection

            12.2.1.5. Salmonellosis

            12.2.1.6. H. pylori Infection

            12.2.1.7. Shigellosis

        12.2.2. Viral Enteric Disease

            12.2.2.1. Rotavirus

            12.2.2.2. Norovirus

        12.2.3. Parasitic Enteric Disease

            12.2.3.1. Amebiasis

            12.2.3.2. Cryptosporidiosis

            12.2.3.3. Giardiasis

    12.3. Asia Pacific Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        12.3.1. Immunoassay Testing

        12.3.2. Conventional Testing

        12.3.3. Molecular Diagnostic Testing

    12.4. Asia Pacific Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        12.4.1. Hospitals

        12.4.2. Diagnostic Laboratories

        12.4.3. Physician Offices

    12.5. Asia Pacific Enteric Disease Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Enteric Disease Testing Market Attractiveness Analysis

        12.6.1. By Disease Indication

        12.6.2. By Testing Methods

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Enteric Disease Testing Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        13.2.1. Bacterial Enteric Disease

            13.2.1.1. Clostridium Difficile Infection

            13.2.1.2. Campylobacteriosis

            13.2.1.3. Cholera

            13.2.1.4. E. coli Infection

            13.2.1.5. Salmonellosis

            13.2.1.6. H. pylori Infection

            13.2.1.7. Shigellosis

        13.2.2. Viral Enteric Disease

            13.2.2.1. Rotavirus

            13.2.2.2. Norovirus

        13.2.3. Parasitic Enteric Disease

            13.2.3.1. Amebiasis

            13.2.3.2. Cryptosporidiosis

            13.2.3.3. Giardiasis

    13.3. Latin America Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        13.3.1. Immunoassay Testing

        13.3.2. Conventional Testing

        13.3.3. Molecular Diagnostic Testing

    13.4. Latin America Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        13.4.1. Hospitals

        13.4.2. Diagnostic Laboratories

        13.4.3. Physician Offices

    13.5. Latin America Enteric Disease Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Enteric Disease Testing Market Attractiveness Analysis

        13.6.1. By Disease Indication

        13.6.2. By Testing Methods

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Enteric Disease Testing Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Enteric Disease Testing Market Value Forecast, by Disease Indication, 2017–2030

        14.2.1. Bacterial Enteric Disease

            14.2.1.1. Clostridium Difficile Infection

            14.2.1.2. Campylobacteriosis

            14.2.1.3. Cholera

            14.2.1.4. E. coli Infection

            14.2.1.5. Salmonellosis

            14.2.1.6. H. pylori Infection

            14.2.1.7. Shigellosis

        14.2.2. Viral Enteric Disease

            14.2.2.1. Rotavirus

            14.2.2.2. Norovirus

        14.2.3. Parasitic Enteric Disease

            14.2.3.1. Amebiasis

            14.2.3.2. Cryptosporidiosis

            14.2.3.3. Giardiasis

    14.3. Middle East & Africa Enteric Disease Testing Market Value Forecast, by Testing Methods, 2017–2030

        14.3.1. Immunoassay Testing

        14.3.2. Conventional Testing

        14.3.3. Molecular Diagnostic Testing

    14.4. Middle East & Africa Enteric Disease Testing Market Value Forecast, by End-user, 2017–2030

        14.4.1. Hospitals

        14.4.2. Diagnostic Laboratories

        14.4.3. Physician Offices

    14.5. Middle East & Africa Enteric Disease Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Enteric Disease Testing Market Attractiveness Analysis

        14.6.1. By Disease Indication

        14.6.2. By Testing Methods

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of companies)

    15.2. Market Share / Position Analysis, by Company, 2018

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. Meridian Bioscience, Inc.

            15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.1.2. Growth Strategies

            15.4.1.3. SWOT Analysis

        15.4.2. Bio-Rad Laboratories, Inc.

            15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.2.2. Growth Strategies

            15.4.2.3. SWOT Analysis

        15.4.3. Alere, Inc.

            15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.3.2. Growth Strategies

            15.4.3.3. SWOT Analysis

        15.4.4. bioMérieux SA

            15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.4.2. Growth Strategies

            15.4.4.3. SWOT Analysis

        15.4.5. Trinity Biotech plc

            15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.5.2. Growth Strategies

            15.4.5.3. SWOT Analysis

        15.4.6. DiaSorin S.p.A.

            15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.6.2. Growth Strategies

            15.4.6.3. SWOT Analysis

        15.4.7. Quest Diagnostics

            15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.7.2. Growth Strategies

            15.4.7.3. SWOT Analysis

        15.4.8. Coris BioConcept

            15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.8.2. Growth Strategies

            15.4.8.3. SWOT Analysis

        15.4.9. TECHLAB, Inc.

            15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.9.2. Growth Strategies

            15.4.9.3. SWOT Analysis

        15.4.10. Pro-Lab Diagnostics, Inc.

            15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.10.2. Growth Strategies

            15.4.10.3. SWOT Analysis


Featured Research Reports

  • Featured Research Reports

    Pulse Electromagnetic Field Therapy Devices Market (By Power: Low Frequency, High Frequency; By Application: Pain Management, Bone Growth; By End-use: Hospitals, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Hospital Consumables Market (By Product: Disposable Medical Gloves, IV Kits, Medical Gauze & Tapes, Disposable Syringes, Sharps Disposable Containers, Catheters, Non-woven Disposable Products, Surgical Blades, Medicine Cups, Cannula, Guidewires, Thermometer, Stethoscope, Glucometer Strips, IV Solutions) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Rat And Mouse Model Market (By Type: Knockout, Knock-in, Outbred, Inbred; By Technology: Nuclear transferase, Microinjection, Embryonic stem cells, CRISPR/Cas9; By Service: Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending; By Application: Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies; By End-use: Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Healthcare ERP Market (By Function: Inventory and Material Management, Supply Chain and Logistics Management, Patient Relationship Management, Finance and Billing; By Deployment: On-premises, Cloud) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Biotechnology & Pharmaceutical Services Outsourcing Market (By Service: Consulting, Auditing and Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education; By End-use: Pharma, Biotech) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...